Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.62)
# 2,051
Out of 5,149 analysts
5
Total ratings
75%
Success rate
29.36%
Average return

Stocks Rated by Matt Dellatorre

Teva Pharmaceutical Industries
Feb 9, 2026
Maintains: Buy
Price Target: $36$45
Current: $32.28
Upside: +39.41%
Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $14.89
Upside: -32.84%